亚当斯蛋白糖酶在胸前大动脉疾病中的作用
Marsioleda Kemberi1, Yousuf Salmasi2, Salvatore Santamaria3
1Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK.
International journal of molecular sciences
|August 12, 2023
概括
胸前大动脉动脉瘤和剖析 (TAAD) 具有挑战性的早期诊断. 细胞外基质中的ADAMTS蛋白质甘酶显示为TAAD诊断和监测疾病进展的生物标志物具有前途.
科学领域:
- 生物化学 生化学
- 心血管生物学 心血管生物学
- 生物标志物发现发现
背景情况:
- 胸前动脉瘤和剖析 (TAAD) 存在重大诊断挑战,通常在剖析后晚诊断.
- 介质变性,以光滑肌肉细胞损失和细胞外矩阵 (ECM) 变化为特征,是TAAD的标志.
- 蛋白质甘油 (PGs) 在大动脉介质中积累,破坏壁面的完整性并增加压力.
研究的目的:
- 在胸前大动脉疾病中审查A Disintegrin-like和甲蛋白酶与血栓松动因子 (ADAMTS) 蛋白质糖酶的作用.
- 探索ADAMTS蛋白糖酶作为TAAD诊断和进展的生物标志物的潜力.
主要方法:
- 文献综述侧重于ADAMTS蛋白糖酶及其在大动脉ECM中的功能.
- 对TAAD小鼠模型的发现进行分析.
- 对TAAD诊断的临床影响的讨论.
主要成果:
- 亚当斯蛋白糖酶在TAAD病变发生过程中起着复杂的作用,影响大动脉ECM中的PG稳态.
- 在PG合成和ADAMTS蛋白酶降解中的不平衡有助于介质退行.
- 鼠标模型强调了这些蛋白酶在TAAD中的关键参与.
结论:
- 亚当斯蛋白质甘酶与TAAD的发展和进展有关.
- 这些蛋白质糖酶为开发用于早期TAAD检测和监测的新生物标志物提供了有前途的途径.
相关概念视频
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Aneurysm III: Interprofessional Care
10
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
10
Aneurysm II: Clinical Manifestations and Diagnostic Studies
10
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
10
Aneurysm I: Introduction
13
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
13
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12


